Marinus Pharmaceuticals I... (MRNS)
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 120.57M | 240.55M | 122.93M | 138.51M | 90.94M | 67.73M | 33.53M | 26.18M | 51.72M | 49.72M | 10.04M | 8.63M |
| Short-Term Investments | 29.72M | n/a | n/a | 1.47M | 739K | 5M | 19.86M | 3.92M | 4.47M | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | 1.47M | n/a | n/a | 24.82M | n/a | 1.49M | n/a | n/a | n/a |
| Other Long-Term Assets | 819K | 14.73M | 11.41M | 6.89M | 2.44M | n/a | 978K | n/a | 376K | 21K | 9.38K | 8.33K |
| Receivables | 3.8M | 6.35M | 3.19M | 1.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 2.41M | 77K | -9.31M | -6.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 8.75M | 5.4M | 5.57M | 4.64M | 4.9M | 2.43M | 1.96M | 398K | 571K | 856K | 1.76M | 31.26K |
| Total Current Assets | 165.25M | 240.55M | 122.93M | 140.16M | 94.13M | 73.94M | 33.53M | 30.3M | 57.77M | 50.15M | 11.8M | 8.67M |
| Property-Plant & Equipment | 4.84M | 4.24M | 2.5M | 1.95M | 2.27M | 1.29M | 1.34M | 1.15M | 31K | 44K | 16.06K | 8.73K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 5.66M | 18.97M | 13.91M | 10.31M | 4.71M | 1.29M | 27.14M | 1.15M | 1.9M | 65K | 25.44K | 17.06K |
| Total Assets | 170.91M | 259.52M | 136.84M | 150.46M | 98.84M | 75.23M | 60.67M | 31.45M | 59.66M | 50.21M | 11.82M | 8.68M |
| Account Payables | 4M | 4.46M | 3.13M | 2.21M | 2.76M | 2.47M | 927K | 2.81M | 3.15M | 536K | 78K | 115.06K |
| Deferred Revenue | n/a | n/a | 15.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 370.16K |
| Short-Term Debt | 14.54M | 1.66M | 556K | 510K | 446K | n/a | n/a | 3.5M | 2.13M | n/a | n/a | 2.67M |
| Other Current Liabilities | 22.09M | 16.45M | 36.88M | 8.01M | 4.82M | 4.44M | 1.62M | 1.77M | 2.16M | 1.5M | 2.29M | 1.71M |
| Total Current Liabilities | 40.62M | 54.87M | 40.57M | 10.73M | 8.03M | 6.91M | 2.54M | 8.08M | 7.43M | 2.04M | 2.37M | 4.5M |
| Long-Term Debt | 95.82M | 72.36M | 42.79M | 2.53M | n/a | n/a | n/a | 1.74M | 5.24M | 7M | n/a | n/a |
| Other Long-Term Liabilities | 152K | 29.86M | n/a | n/a | n/a | n/a | 120K | 141K | 56K | 20K | n/a | n/a |
| Total Long-Term Liabilities | 113.52M | 88.64M | 42.79M | 2.53M | 3.04M | n/a | 120K | 1.88M | 5.31M | 7.02M | n/a | n/a |
| Total Liabilities | 154.14M | 143.52M | 83.35M | 13.26M | 11.07M | 6.91M | 2.66M | 9.97M | 12.74M | 9.06M | 2.37M | 4.5M |
| Total Debt | 110.36M | 72.67M | 40.81M | 510K | 446K | n/a | n/a | 5.24M | 7.38M | 7M | n/a | 2.67M |
| Common Stock | 55K | 50K | 37K | 37K | 87K | 53K | 41K | 20K | 19K | 14K | 494.00 | 479.00 |
| Retained Earnings | -571.93M | -430.52M | -410.7M | -311.93M | -235.57M | -181.45M | -144.73M | -125.83M | -97.19M | -72.34M | -61.5M | -56.23M |
| Comprehensive Income | -20K | n/a | n/a | -0.00 | 0.00 | -2K | -96K | -358K | -349K | -356K | -428.78K | -418.99K |
| Shareholders Equity | 16.77M | 116M | 53.49M | 137.2M | 87.77M | 68.33M | 58.01M | 21.48M | 46.92M | 41.15M | 9.46M | 4.18M |
| Total Investments | 29.72M | n/a | n/a | 2.95M | 739K | 5M | 24.82M | 3.92M | 5.96M | n/a | n/a | n/a |